-
Jun 8, 2016, 15:20 PM
by
Michael Croft
Bio-IT World News Brief | Omicia today announced the completion of a $23 million Series B financing round. Several new investors participated in the round, including UPMC Enterprises, Roche Venture Fund, LDV Partners, Ping An Ventures, and a large genomics investor, as well as existing investors ARTIS Ventures, Acadia Woods Partners and Buchanan Investments.
Full story
-
Jun 8, 2016, 08:11 AM
by
Michael Croft
PRINCETON, NJ - Jun 8, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced that the US Food and Drug Administrations (FDAs) Center for Veterinary Medicine has extended its five-year Cooperative Research and Development Agreement (CRADA) with the company until 2020
Full story
-
Jun 7, 2016, 17:25 PM
by
Michael Croft
MUNICH, GERMANY - Jun 2, 0016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced a partnership agreement with MolecularMD to combine MolecularMDs expertise in specialty diagnostic assays with Definiens quantitative tissue read-outs
Full story
-
Jun 7, 2016, 11:27 AM
by
Michael Croft
CHAPEL HILL, NC, UNITED STATES - Jun 7, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, was recently honored as part of the clinical trial team for the LEAP Trial: Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
Full story
-
Jun 7, 2016, 10:43 AM
by
Michael Croft
ST. LOUIS, UNITED STATES - Jun 7, 2016 - Illumina, Inc. (NASDAQ: ILMN) today announced that the Donald Danforth Plant Science Center is the 2016 recipient of the Agricultural Greater Good Initiative grant
Full story
-
Jun 6, 2016, 12:54 PM
by
Michael Croft
Computerworld | IBM will back efforts to create infrastructure and best practices for the R community, as well as promote use of the language.
Full story
-
Jun 6, 2016, 10:47 AM
by
Michael Croft
STAT | There are 17 biotech companies in the US that generate more than $500 million per year in revenue. And they're increasingly focused on buying innovative new products through mergers and acquisitions, rather than developing them in house.
Full story
-
Jun 3, 2016, 15:05 PM
by
Michael Croft
Bio-IT World News Brief | amfAR, The Foundation for AIDS Research, has awarded seven scientists a total of approximately $1.4 million in research grants to better understand why HIV persists in the body despite effective antiretroviral therapy (ART) and pursue novel pathways to a cure. This round of grants was supported in part by the Foundation for AIDS and Immune Research (FAIR).
Full story
-
Jun 3, 2016, 13:25 PM
by
Michael Croft
Bio-IT World | Best Practices Winner | The U.S. Food and Drug Administration (FDA) commissioner Dr. Robert Califf announced the winners of the first precisionFDA community challenge last month. Awards for the Consistency Challenge were given to Rafael Aldana and his team from Sentieon for Best Performance and Highest Reproducibility, and to Deepak Grover from Sanofi-Genzyme for Highest Accuracy.
Full story
-
Jun 3, 2016, 13:08 PM
by
Michael Croft
Nature News & Comment | Cutting tool could be used to study RNA's role in disease.
Full story
-
Jun 3, 2016, 10:08 AM
by
Michael Croft
Computerworld | It will help reduce the research backlog. Although the current supercomputer has run seven million jobs representing the work of some 10,000 researchers, the Texas center still fields five times as many requests for time on the system as it can deliver.
Full story
-
Jun 2, 2016, 15:00 PM
by
Michael Croft
STAT | Last year, annual global spending on cancer treatments and drugs used for supportive care hit $107 billion, up 11.5 percent from 2014.
Full story
-
Jun 2, 2016, 14:52 PM
by
Michael Croft
Fortune | The Novartis CEO is betting China will play a key role in discovering life-changing drugs. The firm opened an R&D facility in Shanghai.
Full story
-
Jun 2, 2016, 08:18 AM
by
Michael Croft
BETHESDA, MD - Jun 2, 2016 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Harold Varmus, MD, is joining the Alliances board of directors
Full story
-
Jun 1, 2016, 12:40 PM
by
Michael Croft
WILMINGTON, DE, UNITED STATES - Jun 1, 2016 - Eye care is very important segment in the healthcare Industry. Eye related problems are very common when compared to other body problems
Full story
-
May 31, 2016, 16:51 PM
by
Michael Croft
CHAPEL HILL, NC, UNITED STATES - May 31, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that the company was named the 2016 Best CRO by Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham and Chapel Hill region of North Carolina, where Rho is headquartered
Full story
-
May 31, 2016, 11:56 AM
by
Michael Croft
, CA, SAN DIEGO - May 31, 2016 - In todays laboratories the amount of collaborations and information to keep track of seem to be rapidly growing for both academic and industrial scientists
Full story
-
May 31, 2016, 04:15 AM
by
Michael Croft
Bio-IT World | News and products from 10x Genomics, DirectData Networks, BT, The Genome Analysis Centre, Veeva and more.
Full story
-
May 27, 2016, 14:36 PM
by
Michael Croft
DURHAM, NC, UNITED STATES - May 27, 0016 - Cenduit's Upgraded Patient Reminders Tool Enhances Patient Compliance and EngagementUpgraded tool improves sponsor-patient communication with two-way messaging dashboardResearch Triangle Park, NC - May 25, 2016 -Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, today announced the launch of its upgraded Patient RemindersTM tool
Full story
-
May 27, 2016, 05:40 AM
by
Michael Croft
Bio-IT World | Book Review | Merging bioinformatics, computational biology, and technology are clearly important parts of the drug discovery equation. But in his new book, William Loging argues that IT is not a silver bullet, and user-centric design must be a key component.
Full story